Crinetics Pharmaceuticals (CRNX) Other Operating Expenses (2022 - 2026)
Crinetics Pharmaceuticals' (CRNX) quarterly Other Operating Expenses came in at $200000.0 in Q1 2026, down 81.41% quarter-over-quarter from $1.1 million in Q4 2025.
Crinetics Pharmaceuticals (CRNX) Other Operating Expenses (2022 - 2026) Analysis & Trends
Crinetics Pharmaceuticals' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $200000.0 in Q1 2026; TTM through Mar 2026 was $55.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.1 million, changed N/A from the prior year.
- Other Operating Expenses fell to $200000.0 in Q1 2026 per CRNX's latest filing, from $1.1 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $98.6 million in Q4 2022 and bottomed at $200000.0 in Q1 2026.
- The 3-year median for Other Operating Expenses is $27.6 million (2025), against an average of $38.5 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Crinetics Pharmaceuticals | 8.71 Bn | 8.71 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 1.08 Mn |
| Jun 30, 2025 | 54.10 Mn |
| Dec 31, 2022 | 98.56 Mn |